BioCentury | Apr 6, 2015
Emerging Company Profile

Treating H. pylori

ImevaX GmbH is developing a therapeutic vaccine against Helicobacter pylori that could be more effective than standard of care without generating resistance. The company also is developing two diagnostics for the bacterial infection, including a...
Items per page:
1 - 1 of 1